Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disulfiram ("Antabuse"): A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease

NCT03891667 is registered in ClinicalTrials.gov with Research Foundation for Mental Hygiene, Inc. as lead sponsor.

NCT NCT03891667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disulfiram ("Antabuse"): A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease
Lead sponsor
Research Foundation for Mental Hygiene, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2019
Completion date
March 31, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, quality of life